« Back
Home /
Trelagliptin (succinate)

Trelagliptin (succinate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10 mg
Quantity options	100 mg 10mM/1mL 10 mg 50 mg 5 mg
Item no.	HY-15408A-10mg
Targets	Dipeptidyl Peptidase
CASRN	1029877-94-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	SYR-472 succinate
Purity	99.96
Product Description	Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM)[1].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Metabolism-protein/nucleotide metabolism
MolecularWeight	475.47
Clinical_Information	Launched
Manufacturers Research Area	Metabolic Disease
Solubility	DMSO : ≥ 50 mg/mL\|H2O : 100 mg/mL (ultrasonic)
Manufacturers Target	Dipeptidyl Peptidase
Isoform	DPP-4
Pathway	Metabolic Enzyme/Protease

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-15408A-10mg-safety-datasheet.pdf